Cardiovascular Prevention Supported by Digital Technology: Comparison With the Traditional Model
Recruiting
N/A
Interventional Study
Cardiovascular (CV) Risk
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 75
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 144 (estimated)
- Sponsor
- Maria Cecilia Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk.
This study aims to evaluate the effectiveness and feasibility of a cardiovascular prevention pathway delivered remotely through a digital application, comparin…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age between 40 and 75 years
* hypertension
* hyperglycaemia
* type 2 diabetes not requiring insulin therapy
* dyslipidaemia
* active smoking
* overweight/grade I obesity
* Willingness to participate in follow-up visits over 24 months
Exclusion Criteria:
* previous myocardial…
Contacts
No contact information available.